Weed (BUDZ) Share-based Compensation (QoQ) (2010 - 2023)
Weed (BUDZ) Share-based Compensation (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 300.00% |
| Sep 30, 2023 | -300.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -72.99% |
| Sep 30, 2022 | -56.97% |
| Jun 30, 2022 | -38.38% |
| Mar 31, 2022 | 45.46% |
| Dec 31, 2021 | 396.55% |
| Sep 30, 2021 | -95.85% |
| Jun 30, 2021 | 50.41% |
| Mar 31, 2021 | 6.99% |
| Dec 31, 2020 | 1,031.67% |
| Sep 30, 2020 | 108.12% |
| Jun 30, 2020 | -135.13% |
| Mar 31, 2020 | 29.09% |
| Dec 31, 2019 | -73.06% |
| Sep 30, 2019 | 1.10% |
| Jun 30, 2019 | 614.76% |
| Mar 31, 2019 | -97.80% |